California Collaborative Network to Promote Data Driven Care and Improve Outcomes in Early Psychosis (EPI-CAL)

NIH Pandemic-Era Grants

Pandemic Era Grants

2024

Document text

Principal Investigator: Tara Ann Niendam
Organization: UNIVERSITY OF CALIFORNIA AT DAVIS
Fiscal Year: 2024
Award: $1,578,817
Funding agency: National Institute of Mental Health

Project Summary
A prolonged first episode of psychosis (FEP) without adequate treatment is the most consistent predictor of
poor clinical and functional outcomes 1, poor health outcomes 2 and significant economic burden 3. Team-based
“coordinated specialty care” (CSC)4 for early psychosis (EP) has established effectiveness in promoting clinical
and functional recovery 5 . EP treatment programs have expanded rapidly with increased funding across the US
without formal coordination of training or implementation. While EP programs share many features, the lack of
state and national coordination and data infrastructure limits the capacity for large-scale evaluation or
accelerated dissemination of best practices 6. Based on prior collaborations with 30 California (CA) EP
programs and experiences using mobile health (MOBI mHealth) technology to measure individual outcomes in
EP care, the UC Davis (UCD) team is uniquely poised to create EPI-CAL, a CA network that will contribute
systematically collected outcomes data on over 1000 FEP clients per year, from 6 community and 6 university
EP clinics, to a national EP network supported by the NIMH EPINET program. Building on our prior work
evaluating CA EP programs, EPI-CAL programs will participate in a formative evaluation in Year 1 to define
core EP clinical features, intervention targets, and outcomes needed to harmonize network input. A “core
battery” based on current measures collected at the sites, the PhenX toolkit 7 and expanded to cover all critical
domains, will be installed across the network in Year 2. Core client outcomes and metrics of data use for
treatment decisions will be collected using the custom MOBI mHealth data network at the client, program, and
state level to allow easy data analysis, interpretation and dissemination. Training and ongoing monitoring will
be provided at all EPI-CAL sites to ensure appropriate implementation. EPI-CAL will contribute de-identified
data to the national coordinating hub. Using the RE-AIM implementation science framework 8,9, we will
systematically evaluate the impact of MOBI on EP programs across 5 dimensions: reach, efficacy, adoption,
implementation, and maintenance (see Figure 1). To demonstrate the network’s research capacity, in the R34
component of this application, we propose to develop and validate a measure of the Duration of Untreated
Psychosis (DUP) that is feasible for use in community settings and psychometrically sound. Although DUP is a
significant predictor of both short-term CSC treatment response5 and long-term outcomes 10 for FEP, no
measure currently exists that has been rigorously validated and is feasible for use by community providers 7,11.
We will utilize stakeholder feedback (clients, family members, academic experts and CSC staff) to develop a
tool with standardized DUP definitions that includes anchored assessment of psychosis onset and start of
treatment. Developing such a tool will allow standardized assessment of this critical moderator of CSC
outcomes across the entire EPINET.

Terms: <Acceleration><Address><Adoption><California><Caring><Client><Client satisfaction><Clinic><Clinical><Collaborations><Communities><Coordinated Specialty Care><Custom><Data><Data Analyses><Data Analysis><Development><Dimensions><Economic Burden><Effectiveness><Eligibility><Eligibility Determination><Enrollment><Ensure><Equipment and supply inventories><Evaluation><Family member><Feedback><Funding><Individual><Intervention><Intervention Strategies><Inventory><Maintenance><Measures><Monitor><NIMH><National Institute of Mental Health><Outcome><Participant><Patient Satisfaction><PhenX Toolkit><Phenotypes and eXposures Toolkit><Phenx><Protocol Screening><Provider><Psychometrics><Psychoses><QOL><Quality of life><RE-AIM><Reach, Effectiveness, Adoption, Implementation, and Maintenance><Recovery of Function><Reference Standards><Reporting><Research><Schizophrenia><Schizophrenic Disorders><Severities><Site><Standardization><Symptoms><Target Populations><Technology><Testing><Time><Training><Universities><Validation><Work><acceptability and feasibility><barriers to implementation><care outcomes><care providers><clinical care><community setting><customs><dashboard><data de-identification><data deidentification><data infrastructure><data integration><data interpretation><data visualization><de-identified data><deidentified data><dementia praecox><developmental><duration of untreated psychosis><early psychosis><enroll><evidence base><experience><first episode psychosis><formative assessment><formative evaluation><functional outcomes><functional recovery><health care outcomes><healthcare outcomes><implementation barriers><implementation challenges><implementation framework><implementation research framework><implementation science framework><improved><improved outcome><innovate><innovation><innovative><interventional strategy><m-Health><mHealth><mobile health><novel><poor health outcome><programs><psychotic symptoms><reach, efficacy, adoption, implementation, and maintenance><reduced health outcome><response to therapy><response to treatment><schizophrenic><sound><support network><technology platform><technology system><therapeutic response><therapy response><tool><treatment choice><treatment planning><treatment program><treatment response><treatment responsiveness><validations><worse health outcome>